The Indus Entrepreneurs (TiE), a nonprofit venture devoted to entrepreneurs in all industries, held a discussion on the role of interventional medical devices at their meeting this July in southern California. Panelists at this event were Ajit Mishra, Sanjay Srivastava, and Dr. Santosh Kookal, while I was the moderator.
Srivastava noted that investment in the interventional medical device sector is about 3% or approximately $100 billion of the total medical industry-wide investment. Approximately sixteen million people suffer strokes which cost the healthcare industry $15 billion for medical care, whereas six million people suffer from heart attacks costing the industry around $20 billion, he said.
Dr. Kookal emphasized the role of software in pinpointing medical problems as it can handle a lot of sampling data and analyze it for better solutions. He felt that software development was going ahead in the right direction.
Mishra added it is better and more cost effective to prevent a problem than to treat it after it occurs. The cost of treatment for a stroke or heart attack is far greater than preventive treatment.
The panelists pointed out that before investing in a healthcare company one should research, check the company’s profit and loss, and find out how well it was performing. TiE-SoCal president Smita Bagla thanked the attendees and panelists for their participation.
Last updated: December 26th, 2025
